Affinity Investment Advisors, LLC Catalyst Pharmaceuticals, Inc. Transaction History

Affinity Investment Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$11.78 - $17.29 $253,034 - $371,389	-21,480 Reduced 44.07%	27,260 $458,000
Q3 2023 Oct 26, 2023	SELL	$11.69 - $15.02 $8,066 - $10,363	-690 Reduced 1.4%	48,740 $569,000
Q2 2023 Aug 10, 2023	SELL	$11.5 - $18.08 $190,946 - $300,200	-16,604 Reduced 25.14%	49,430 $664,000
Q1 2023 May 05, 2023	SELL	$14.34 - $21.05 $2,050 - $3,010	-143 Reduced 0.22%	66,034 $1.09 Million
Q4 2022 Feb 08, 2023	SELL	$12.25 - $19.5 $302,415 - $481,396	-24,687 Reduced 27.17%	66,177 $1.23 Million
Q1 2022 May 05, 2022	BUY	$5.31 - $8.31 $482,487 - $755,079	90,864 New	90,864 $753,000

326

94.6M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Affinity Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Affinity Investment Advisors, LLC with notifications on news.